Clinical Trials Logo

Filter by:
NCT ID: NCT04428242 Withdrawn - Clinical trials for Macular Degeneration

Study Evaluating Retinal Health Monitoring System Thickness Module

Start date: April 2020
Phase:
Study type: Observational

Evaluate the ability and accuracy of the Retinal Health Monitoring System - Retinal Thickness Module (RHMS - RTM).

NCT ID: NCT04575285 Withdrawn - Major Depression Clinical Trials

Using EEG to Predict Depression Treatment Response to rTMS in Patients With Major Depression

Start date: April 2020
Phase:
Study type: Observational

Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising, novel, non-invasive therapy for depression. The study is looking at changes in specific electroencephalogram parameters in depressed patients treated with rTMS can serve as predictors of depression treatment response among cancer patents undergoing rTMS treatment of depression.

NCT ID: NCT03707418 Withdrawn - Clinical trials for Extracorporeal Membrane Oxygenation Complication

Bivalirudin vs Heparin in ECMO Patients

Start date: April 2021
Phase: Phase 1
Study type: Interventional

This is an open label, randomized study comparing the clinical outcomes of unfractionated Heparin and Bivalirudin for anticoagulation in adult subjects requiring ECMO support.

NCT ID: NCT04014712 Withdrawn - COPD Clinical Trials

O2 Transport and Utilization in Health and Lung Disease

Start date: April 2021
Phase: Phase 1
Study type: Interventional

Skeletal muscle dysfunction is a frequent and clinically relevant systemic manifestation of Chronic Pulmonary Obstructive Disease (COPD), which is still poorly understood. Therefore, the focus of this study is on the role of a deficit in tetrahydrobiopterin and nitric oxide synthase uncoupling induced by chronic oxidative stress on metabolic and vascular abnormalities in skeletal muscle of patients suffering from COPD.

NCT ID: NCT04026464 Withdrawn - Clinical trials for Patent Ductus Arteriosus

Addition of Acetaminophen in Standard PDA Management

Start date: April 2021
Phase: Phase 2
Study type: Interventional

Patent ductus arteriosus is a common morbidity in preterm infants and management of PDA varies among neonatologist. The investigators are conducting a randomized controlled trial to determine the rates of initial patent ductus arteriosus (PDA) closure after completion of a first treatment course.

NCT ID: NCT04054323 Withdrawn - Clinical trials for Chronic Kidney Diseases

The Efficacy of Physical Activity on Improving Health Outcomes for Renal Transplant Patients and Their Caregivers

Start date: April 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to see whether a physical activity intervention improves fitness, strength and reduces sedentary behavior. The investigators are also interested in determining if changes will improve quality of life and outcomes associated with renal transplant waitlist.

NCT ID: NCT04101292 Withdrawn - Colorectal Cancer Clinical Trials

Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)

Start date: April 2021
Phase: N/A
Study type: Interventional

The Institute of Image-Guided Surgery (IHU) of Strasbourg is a translational research Institute aiming to develop hybrid surgery techniques. The IHU-SPECTRA research unit, entirely dedicated to the development of fluorescence-guided surgery, was set up to test several innovations as part of a large-scale project (ELIOS: Endoscopic Luminescent Imaging for Precision Oncology Surgery), funded by the ARC Foundation for Cancer Research. The proposed research protocol is part of the ELIOS project and targets in particular colon tumours. The Holy Grail in oncology surgery is the radical removal of cancer cells in order to reduce the rate of tumour recurrences and increase the tumour's free survival. The administration of a tumour-specific antibody, which fluoresces in the Near-Infrared ranges and which could be univocally recognized at a tumour cellular level, could provide a rapid and accurate evaluation of radical tumour removal. The University Medical Center Groningen (UMCG) has developed a fluorescent tracer coupling Bevacizumab (which targets the Vascular Endothelial Growth Factor = VEGF) with a fluorescent dye, the IRDye800. The initial human results are very promising and no adverse events linked to the fluorescent molecule have been reported. In parallel, an alternative optical technique that does not require the use of a fluorophore, the Hyperspectral Imaging (HSI), is a relatively new method used in image-guided and precision surgery. The company Diaspective Vision GmbH (Pepelw, Germany) produces a HSI camera, the TIVITA system, enabling to obtain spectral information from the tissues. The main advantage of HSI over fluorescence imaging is in that it is a contrast-free imaging and intrinsically quantitative although it does not provide real-time videos. Another innovative optical imaging technology available at the IHU is FF-OCT (Light-CT Scanner, LLTechSAS, Paris, France) which allows non-destructive and high-resolution optical biopsy without tissue treatment. The working hypothesis is that molecular fluorescence enhanced-reality allows greater precision in the differentiation of tumour tissue and healthy tissue in patients with colorectal cancer compared to the immunohistochemistry conventionally used in anatomopathology. In parallel, this technique will be compared to hyperspectral imaging (HSI TIVITA system) and optical imaging (FF-OCT system), two potentially advantageous methods for the detection of tumour tissue.

NCT ID: NCT04207424 Withdrawn - Morbid Obesity Clinical Trials

Embolization of Arterial Gastric Supply in Obesity

Embargo
Start date: April 2021
Phase: N/A
Study type: Interventional

This study aims to assess safety and efficacy of bariatric embolization of the gastro-epiploic arcade using 300-500 micrometres calibrated polyvinyl-alcohol microparticles, for patients with morbid obesity.

NCT ID: NCT04227626 Withdrawn - Type 1 Diabetes Clinical Trials

Inpatient Closed Loop Glucose Control With the Gen 2 GlucoSTAT

Start date: April 2021
Phase: N/A
Study type: Interventional

The goal of this study is to perform a first-in-humans trial of a fully integrated, automated, closed-loop blood glucose control system designed for inpatient use. The GlucoSTAT was designed for use by patients with diabetes while they are in the hospital, and others who may develop high blood sugar as a result of their medical problems.

NCT ID: NCT04230720 Withdrawn - Cataract Clinical Trials

Effect of Artificial Tears on Biometry

Start date: April 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if measurements for cataract surgery are improved with use of additional lubrication with artificial tears. The research study is being done to optimize measurements and provide patients with the best visual outcomes after cataract surgery.